Our Blog | Biosimilars & Generics | AAM

In the News - AAM CEO Dan Leonard shares the industry's 2021 outlook with Chain Drug Review.

Jan 6, 2021 | Dan Leonard

2021 Generics and Biosimilars Outlook

Jean Hoffman

Jan 4, 2021 | Bob Billings

Thank you, Jean Hoffman

Helen, 41, from Florida, knows she can rely on biosimilars for her non-Hodgkin lymphoma

Dec 17, 2020 | Erica Klinger

Helen Knows She Can Rely on Biosimilars

GRx+Biosims 2020 Recap

Dec 17, 2020 | Erica Klinger

GRx+Biosims Recap: A Virtual Success

Oppose the Blocking Act #Preserve180

Dec 14, 2020 | Dan Leonard

Congress Should Preserve—Not Limit—Patient Access to New Generics

Catholic Medical Mission Board (CMMB)

Dec 4, 2020 | Jewel Smith

A World of Difference: Associate Member CMMB’s Global Health Mission

State Savings Map

Nov 25, 2020 | Erica Klinger

Health Care Savings, State by State

Sandoz office

Nov 2, 2020 | Jewel Smith

Member Spotlight: Sandoz

Oct 29, 2020 | Erica Klinger

Top 10 Ways to Commemorate 10 Years of Biosimilars in the U.S.

Milan “Mike” Puskar

Oct 23, 2020 | Bob Billings

Thank you, Mike Puskar

Oct 20, 2020 | Sara Skubikowski

Adding up the Generic Savings for Americans with Cancer and Other Conditions

Biosimilars patient Jeni, 35, from Santa Clarita, CA

Oct 15, 2020 | Erica Klinger

Jeni Got Her Life Back, Thanks to a Biosimilar